206 related articles for article (PubMed ID: 34119079)
1. Vignette-Based Utilities: Usefulness, Limitations, and Methodological Recommendations.
Matza LS; Stewart KD; Lloyd AJ; Rowen D; Brazier JE
Value Health; 2021 Jun; 24(6):812-821. PubMed ID: 34119079
[TBL] [Abstract][Full Text] [Related]
2. Trends in the measurement of health utilities in published cost-utility analyses.
Brauer CA; Rosen AB; Greenberg D; Neumann PJ
Value Health; 2006; 9(4):213-8. PubMed ID: 16903990
[TBL] [Abstract][Full Text] [Related]
3. Challenges in health state valuation in paediatric economic evaluation: are QALYs contraindicated?
Ungar WJ
Pharmacoeconomics; 2011 Aug; 29(8):641-52. PubMed ID: 21604821
[TBL] [Abstract][Full Text] [Related]
4. Application of classic utilities to published pediatric cost-utility studies.
Finnell SM; Carroll AE; Downs SM
Acad Pediatr; 2012; 12(3):219-28. PubMed ID: 22075466
[TBL] [Abstract][Full Text] [Related]
5. Estimating health state utilities associated with a rare disease: familial chylomicronemia syndrome (FCS).
Matza LS; Phillips GA; Howell TA; Ciffone N; Ahmad Z
J Med Econ; 2020 Sep; 23(9):978-984. PubMed ID: 32479143
[No Abstract] [Full Text] [Related]
6. Using Published Health Utilities in Cost-Utility Analyses: Discrepancies and Issues in Cardiovascular Disease.
Zhou T; Chen Z; Li H; Xie F
Med Decis Making; 2021 Aug; 41(6):685-692. PubMed ID: 33813938
[TBL] [Abstract][Full Text] [Related]
7. Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health.
Griebsch I; Coast J; Brown J
Pediatrics; 2005 May; 115(5):e600-14. PubMed ID: 15867026
[TBL] [Abstract][Full Text] [Related]
8. Health state utilities associated with caring for an individual with cutaneous T-cell lymphoma (CTCL).
Williams K; Gibson A; McNamara L; Jones T; Lloyd AJ
J Med Econ; 2020 Oct; 23(10):1142-1150. PubMed ID: 32644862
[TBL] [Abstract][Full Text] [Related]
9. A Systematic Review and Meta-analysis of Childhood Health Utilities.
Kwon J; Kim SW; Ungar WJ; Tsiplova K; Madan J; Petrou S
Med Decis Making; 2018 Apr; 38(3):277-305. PubMed ID: 28990449
[TBL] [Abstract][Full Text] [Related]
10. Estimation of Health State Utility Values in Fabry Disease Using Vignette Development and Valuation.
Hughes D; Lenny A; Shah K; Longworth L; Devercelli G; Ayodele O
J Health Econ Outcomes Res; 2023; 10(1):80-88. PubMed ID: 37064293
[No Abstract] [Full Text] [Related]
11. Identification, Review, and Use of Health State Utilities in Cost-Effectiveness Models: An ISPOR Good Practices for Outcomes Research Task Force Report.
Brazier J; Ara R; Azzabi I; Busschbach J; Chevrou-Séverac H; Crawford B; Cruz L; Karnon J; Lloyd A; Paisley S; Pickard AS
Value Health; 2019 Mar; 22(3):267-275. PubMed ID: 30832964
[TBL] [Abstract][Full Text] [Related]
12. Systematic methodological review of health state values in glaucoma cost-utility analyses.
Kennedy K; Sarohia G; Podbielski D; Pickard S; Tarride JE; Xie F
Eur J Health Econ; 2024 Feb; ():. PubMed ID: 38411844
[TBL] [Abstract][Full Text] [Related]
13. Systematic Review of Health State Utility Values Used in European Pharmacoeconomic Evaluations for Chronic Hepatitis C: Impact on Cost-Effectiveness Results.
Han R; François C; Toumi M
Appl Health Econ Health Policy; 2021 Jan; 19(1):29-44. PubMed ID: 32661846
[TBL] [Abstract][Full Text] [Related]
14. Using qualitative methods to inform the trade-off between content validity and consistency in utility assessment: the example of type 2 diabetes and Alzheimer's disease.
McGrath C; Rofail D; Gargon E; Abetz L
Health Qual Life Outcomes; 2010 Feb; 8():23. PubMed ID: 20152041
[TBL] [Abstract][Full Text] [Related]
15. Comparison of health state utility estimates from instrument-based and vignette-based methods: a case study in kidney disease.
Briggs AH; Belozeroff V; Feeny D
BMC Res Notes; 2019 Jul; 12(1):385. PubMed ID: 31286995
[TBL] [Abstract][Full Text] [Related]
16. Health-state utility estimates for health technology assessment: a review of the manufacturers' submissions to the French National Authority for Health.
Hamers FF; Ghabri S; Le Gales C
Expert Rev Pharmacoecon Outcomes Res; 2017 Oct; 17(5):489-494. PubMed ID: 28133977
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of health utility in trial-based cost-utility analyses for major cardiovascular disease: protocol for a systematic review.
Nakao Y; Kawakami H; Miyazaki S; Saito M; Luo Y; Yamamoto K; Yamaguchi O
BMJ Open; 2023 May; 13(5):e067045. PubMed ID: 37160387
[TBL] [Abstract][Full Text] [Related]
18. Mapping clinical outcomes to generic preference-based outcome measures: development and comparison of methods.
Hernández Alava M; Wailoo A; Pudney S; Gray L; Manca A
Health Technol Assess; 2020 Jun; 24(34):1-68. PubMed ID: 32613941
[TBL] [Abstract][Full Text] [Related]
19. Patterns, trends and methodological associations in the measurement and valuation of childhood health utilities.
Kwon J; Kim SW; Ungar WJ; Tsiplova K; Madan J; Petrou S
Qual Life Res; 2019 Jul; 28(7):1705-1724. PubMed ID: 30783876
[TBL] [Abstract][Full Text] [Related]
20. Eliciting Health State Utilities for Aromatic L-Amino Acid Decarboxylase (AADC) Deficiency: A Vignette Study in France.
Smith AB; Hanbury A; Beitia Ortiz de Zarate I; Hammes F; de Pouvourville G; Buesch K
Patient Relat Outcome Meas; 2021; 12():237-246. PubMed ID: 34285619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
